The University of Warwick Library - WebBridge
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo) : an open-label, 2×2 factorial randomised phase 3 trial
Earl,
Helena M..
The Lancet Oncology.
v.
Volume 15.
no.
Number 2.
2014-02-01.
p.
201 -
212...
issn:
1470-2045
.
Sorry - based on the information provided, WebBridge cannot offer appropriate links.